CD4+/CD56+ Hematodermic Tumor

Marco Herling(TH Köln - University of Applied Sciences), Dan Jones(The University of Texas MD Anderson Cancer Center)

American Journal of Clinical Pathology

April 18, 2007

10.1309/fy6pk436nbk0ryd4

Cited by 172

Related Papers

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

|Nature Communications|2018|105

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

|Cancers|2019|66

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

|Molecular Cancer|2015|24

Lilienthal N et al., Immunokinase-based B-lymphotoxic delivery of activated DAPK1; Supplements from A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells

|Unknown|2023|0